LifeMine Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
114
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$175M
- Investors
-
16
LifeMine General Information
Description
Developer of a drug discovery platform designed to elucidate human biology and create sophisticated therapeutics that attack the fundamental drivers of serious human diseases. The company's platform offers mining of fungal biodiversity to develop mechanistically and structurally novel therapeutics to address previously intractable therapeutic challenges, enabling healthcare providers to treat intractable human diseases via biological mechanisms.
Contact Information
Website
www.lifeminetx.comCorporate Office
- Cambridge Discovery Park
- 30 Acorn Park Drive
- Cambridge, MA 02140
- United States
Corporate Office
- Cambridge Discovery Park
- 30 Acorn Park Drive
- Cambridge, MA 02140
- United States
LifeMine Timeline
LifeMine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series C) | 01-Mar-2022 | $175M | Completed | Generating Revenue | ||
| 2. Later Stage VC (Series B) | 07-Jan-2021 | Completed | Startup | |||
| 1. Early Stage VC (Series A) | 15-Sep-2017 | $75.1M | $75.1M | Completed | Startup |
LifeMine Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A2 | 38,862,045 | $0.000100 | $0.93 | $0.93 | 1x | $0.93 | 15.08% | |
| Series A1 | 47,836,085 | $0.000100 | $0.76 | $0.76 | 1x | $0.76 | 18.56% |
LifeMine Comparisons
Industry
Financing
Details
LifeMine Competitors (50)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Snipr Biome | Venture Capital-Backed | Copenhagen, Denmark | ||||
| Rheos Medicines | Venture Capital-Backed | Cambridge, MA | ||||
| Synlogic | Formerly VC-backed | Cambridge, MA | ||||
| Eligo Bioscience | Venture Capital-Backed | Paris, France | ||||
| Armata Pharmaceuticals | Formerly VC-backed | Marina del Rey, CA |
LifeMine Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
LifeMine Patents
LifeMine Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023205127-A1 | Computational method to identify gene networks containing functionally-related genes | Pending | 07-Jan-2022 | ||
| AU-2022397403-A1 | Deep learning methods for biosynthetic gene cluster discovery | Pending | 23-Nov-2021 | ||
| CA-3238783-A1 | Deep learning methods for biosynthetic gene cluster discovery | Pending | 23-Nov-2021 | ||
| EP-4437546-A1 | Deep learning methods for biosynthetic gene cluster discovery | Pending | 23-Nov-2021 | ||
| CA-3237738-A1 | Methods and systems for discovery of non-embedded target genes | Pending | 16-Nov-2021 | G16B30/10 |
LifeMine Executive Team (10)
| Name | Title | Board Seat |
|---|---|---|
| Weiqing Zhou | Co-Founder and Chief Operating Officer | |
| Martin Stahl | Chief Scientific Officer | |
| Lihua Yu Ph.D | Chief Data Officer | |
| Hingge Hsu MD | Co-Founder | |
| Karen Guarco | Senior Vice President of Finance and Research Operations |
LifeMine Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Edward Hu Ph.D | WuXi Healthcare Ventures | Board Member | |
| Gregory Verdine Ph.D | Self | Co-Founder, President, Chief Executive Officer, Chief Technology Officer and Board Member | |
| Jennifer Jarrett | Self | Board Member | |
| Krishna Yeshwant MD | GV | Board Member | |
| Richard Klausner MD | Self | Co-Founder and Chairman |
LifeMine Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
LifeMine Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3W Partners Capital | PE/Buyout | Minority | ||
| 6 Dimensions Capital | Venture Capital | Minority | ||
| Fidelity Management & Research | Asset Manager | Minority | ||
| GSK | Corporation | Minority | ||
| The Invus Group | PE/Buyout | Minority |
LifeMine FAQs
-
When was LifeMine founded?
LifeMine was founded in 2016.
-
Who is the founder of LifeMine?
Weiqing Zhou, Hingge Hsu MD, Gregory Verdine Ph.D, Brian Bowman, and Richard Klausner MD are the founders of LifeMine.
-
Who is the CEO of LifeMine?
Gregory Verdine Ph.D is the CEO of LifeMine.
-
Where is LifeMine headquartered?
LifeMine is headquartered in Cambridge, MA.
-
What is the size of LifeMine?
LifeMine has 114 total employees.
-
What industry is LifeMine in?
LifeMine’s primary industry is Drug Discovery.
-
Is LifeMine a private or public company?
LifeMine is a Private company.
-
What is the current valuation of LifeMine?
The current valuation of LifeMine is .
-
What is LifeMine’s current revenue?
The current revenue for LifeMine is .
-
How much funding has LifeMine raised over time?
LifeMine has raised $300M.
-
Who are LifeMine’s investors?
3W Partners Capital, 6 Dimensions Capital, Fidelity Management & Research, GSK, and The Invus Group are 5 of 16 investors who have invested in LifeMine.
-
Who are LifeMine’s competitors?
Snipr Biome, Rheos Medicines, Synlogic, Eligo Bioscience, and Armata Pharmaceuticals are some of the 50 competitors of LifeMine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
